Lucine Fahy
Overview
Explore the profile of Lucine Fahy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Maout C, Fahy L, Renou L, Devanand C, Duwat C, Barroca V, et al.
Biomed Pharmacother
. 2024 Jul;
177:117039.
PMID: 38955085
T-cell acute lymphoblastic leukemia (T-ALL) is a malignant hematological disorder characterized by an increased proliferation of immature T lymphocytes precursors. T-ALL treatment includes chemotherapy with strong side effects, and patients...
2.
Fahy L, Calvo J, Chabi S, Renou L, Le Maout C, Poglio S, et al.
Blood Adv
. 2021 Jan;
5(2):513-526.
PMID: 33496749
Resistance to chemotherapy, a major therapeutic challenge in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), can be driven by interactions between leukemic cells and the microenvironment that promote survival...
3.
Chabi S, Uzan B, Naguibneva I, Rucci J, Fahy L, Calvo J, et al.
Cell Rep
. 2019 Nov;
29(8):2307-2320.e6.
PMID: 31747603
Hypoxia plays a major role in the physiology of hematopoietic and immune niches. Important clues from works in mouse have paved the way to investigate the role of low O...
4.
Calvo J, Fahy L, Uzan B, Pflumio F
Adv Biol Regul
. 2019 Aug;
74:100640.
PMID: 31378700
T-cell acute leukemia is a hematologic malignancy that results from the progressive acquisition of genomic abnormalities in T-cell progenitors/precursors. T-ALL is commonly thought to originate from the thymus albeit recent...